Liquid biopsy revolution: How multi-cancer early detection is rewriting oncology
Imagine intercepting a malignant tumor months or even years before a single symptom manifests. A massive NHS clinical trial in the UK is currently evaluating a single-draw Multi-Cancer Early Detection (MCED) test that aims to shift cancer care from reactive treatment to preemptive interception. The Molecular Mechanism: Deciphering Epigenetic Fingerprints …









